Progress in the treatment of ovarian cancer
Paves the way for the development of new targeted therapies Researchers from Yale University have gone to discoveries on how evolving ovarian cancer, which they believe will lead them one step closer to designing new therapies for the disease.
Researchers applying sophisticated methods to record the sequence of genes failed to identify a link between the two main theories about how cancer develops.
More detail of Progress in the treatment of ovarian cancer:
 |
| Progress in the treatment of ovarian cancer |
According to the first approach to a volume there is hardly detectable nucleus of tumor cells that triggers the development of the tumor.
According to the second approach a significant role in tumor growth plays the microenvironment surrounding tumor cells and feeds. The researchers were able to identify a molecular pathway that allows the interaction of the two approaches. Is a molecular connection between the cellular factor and the protein Lin28 BMP4.Progress in the treatment of ovarian cancer
The survey is that it opens the way for the development of new targeted therapies for ovarian cancer, which is difficult to diagnose and treat as indicated by the head researcher Dr Yingqun Huang Assistant Professor, Department of Obstetrics, Gynecology and Reproductive Sciences at the University of Yale. H research published online in the site of the Cell Cycle. ENTERTAINMENTS
